- The Patria vaccine is the first developed in Mexico against Covid-19 and could be ready during the first half of 2023.
- Clinical stage 2R concluded that it is safe and capable of producing a protective response as reinforcement.
- The recruitment of volunteers for the final stage is open and at least 3,860 people are required.
Despite the adversities and the constant changes of date, the development of the homeland vaccine still stands. The technology was promoted by the government of Mexico, through the alliance of National Council for Science and Technology (Conacyt) with Laboratorio Avi-Mex, SA de CV In fact, it is expected that it will register the results of the final stage of clinical development in the first half of 2023, to move towards emergency authorization.
First Mexican vaccine against Covid-19
The homeland vaccine, of Mexican manufacturing, is an effort that brings together the determined work of scientists, men and women scientists, technologists of the country, in a public-private alliance. The data, so far, show that it is a safe development and capable of producing a protective response against the SARS-CoV-2 virus, responsible for Covid-19, as a reinforcement.
The project has already successfully passed phase 1 and 2 preclinical and clinical trials. The preclinical phase yielded safety and efficacy results in living beings. Clinical phase 1 demonstrated that it is safe and capable of generating immunity in humans. While now the 2R clinical stage concluded that it is safe and capable of producing a protective response as reinforcement.
The final stage of clinical development is in the recruitment of at least 3,860 volunteers, under a protocol approved by the National Committee for Science Technology and Innovation in Public Health (CNCTI-SP) and the Federal Commission for the Protection against Sanitary Risks (Cofepris).
For this stage, eleven sites have been set up in various cities of the country (four in Mexico City, one in Oaxaca de Juárez, three in Mérida, one in Morelia, one in Tlalnepantla and one in Acapulco), where they have been voluntarily vaccinated. more than 500 people to date, which makes it possible to estimate the end of recruitment and the first results in 2023. More clinical research sites will soon be enabled to speed up recruitment and application of the vaccine; It should be noted that the infrastructure includes public research sites.
Volunteers are requested to test the biological
The recruitment of volunteers and volunteers is still in force. Registration is open and is available at this link where you can check the requirements. Some of the main ones are: being 18 years of age or older, having at least one dose of vaccine against COVID-19, having let four months pass since the last application of a vaccine or booster; In case of being a woman, not be lactating or pregnant.
With the Homeland vaccine against COVID-19Mexico advances in the recovery of vaccine sovereignty in favor of the life and health of people to guarantee the full right to enjoy the benefits that science, technology and innovation produce.
This recovery has gone through a broad and diligent process of articulating public and private capacities to promote, in parallel with its development, clinical research in the country, the improvement of industrial plants for the development of vaccines for new variants and other diseases, as well as such as laboratory equipment with different levels of biosafety that allow pathogens with low, medium and high levels of danger to be handled.
Also read:
Mexican vaccine ‘Patria’ will be combined: intranasal and intramuscular
List of Mexican and foreign doctors behind the ‘Patria’ vaccine
The first Mexican vaccine against Covid-19 already has a tentative name: Patria